WO2025114603 - PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF FUNGAL INFECTIONS

National phase entry is expected:
Publication Number WO/2025/114603
Publication Date 05.06.2025
International Application No. PCT/EP2024/084318
International Filing Date 02.12.2024
Title [English] PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF FUNGAL INFECTIONS [French] COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT D'INFECTIONS FONGIQUES
Applicants ** BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL Hegenheimermattweg 167b 4123 Allschwil, CH
Inventors ** ENGELHARDT, Marc Basilea Pharmaceutica International Ltd, Allschwil Hegenheimermattweg 167b 4123 Allschwil, CH KELLENBERGER, Laurenz Basilea Pharmaceutica International Ltd, Allschwil Hegenheimermattweg 167b 4123 Allschwil, CH LITHERLAND, Karine Basilea Pharmaceutica International Ltd, Allschwil Hegenheimermattweg 167b 4123 Allschwil, CH
Priority Data 23213359.5  30.11.2023  EP
front page image
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 2221
EPO Filing, Examination 14139
Japan Filing 571
South Korea Filing 578
USA Filing, Examination 9885
MasterCard Visa
Total: 27394
Abstract [English] The present invention provides combinations comprising (a) a compound of formula (I) wherein M(III) is an ion selected from Al, Fe and Ga; or a pharmaceutically acceptable salt thereof, and (b) a triazole-based antifungal agent or a pharmaceutically acceptable salt thereof, as well as methods of using the combinations in the prevention and treatment of fungal infections. [French] La présente invention concerne des combinaisons comprenant (a) un composé de formule (I) dans laquelle M (III) est un ion choisi parmi Al, Fe et Ga, ou un sel pharmaceutiquement acceptable de celui-ci, et (b) un agent antifongique à base de triazole ou un sel pharmaceutiquement acceptable de celui-ci, ainsi que des méthodes d'utilisation des combinaisons dans la prévention et le traitement d'infections fongiques.